CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 4.670
+0.016 (0.34%)
Jul 14, 2025, 5:38 PM CET
CureVac Market Cap
CureVac has a market cap or net worth of €1.05 billion as of July 14, 2025. Its market cap has increased by 41.72% in one year.
Market Cap
1.05B
Enterprise Value
680.72M
Revenue
523.70M
Ranking
n/a
PE Ratio
5.82
Stock Price
€4.67
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 1.05B, a decrease of -87.35%. That is a compound annual growth rate of -34.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 1.05B | 42.29% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 51.36B |
| Merck KGaA | 49.04B |
| Bayer Aktiengesellschaft | 26.86B |
| Fresenius SE & Co. KGaA | 23.62B |
| Sartorius Aktiengesellschaft | 13.71B |
| Fresenius Medical Care AG | 13.57B |
| Fielmann Group AG | 4.90B |
| Carl Zeiss Meditec AG | 4.56B |